A Site Master File (SMF) in pharmaceutical production is a document that contains information and descriptions about a pharmaceutical manufacturing site and its facilities. It is created and maintained by the pharmaceutical manufacturer and is an important part of the documentation required to ensure compliance with Good Manufacturing Practice (GMP) and regulatory standards.

A Site Master File contains the following elements and information, among others:

• Information about the site: This includes the name and location of the pharmaceutical manufacturing site and a physical description of the site, including a map and floor plan of the premises.
• Staff information: List and qualifications of key staff working on site, including training, experience and areas of responsibility.
• Description of production processes: A detailed description of all production processes, including the equipment used (German translation: Ausrüstung), information about the manufactured products, quality control methods and other technical details.
• Information on quality control: Information on the quality control system (German: Qualitätskontrollsystem), including analytical and testing methods used to ensure drug quality.
• Information on distribution and transportation: Description of the conditions for the distribution of the manufactured drugs, including their transportation. The pharmaceutical company must ensure that the drugs manufactured are only supplied to authorized parties and do not enter the illegal supply chain (translation into German: illegale Vertriebskette).
• Information on certifications and licenses: Copies of relevant certificates and licenses issued by regulatory authorities (German translation: Zulassungsbehörden) authorizing the pharmaceutical manufacturing site to manufacture products.
• Information about changes and updates: Procedures and guidelines for changes at the production site, including updates to production processes or quality control systems.

The production site dossier (Site Master File) is an important document for the evaluation and approval of the production site by regulatory authorities and customers as well as for ensuring compliance with GMP standards and quality assurance of the manufactured drugs. It can also be presented in the event of inspections and pharmaceutical production audits.

If your pharmaceutical company is due for a GMP inspection, we look forward to hearing from you. We can provide you with qualified pharmaceutical interpreters and GMP translators who will accompany you on-site or remotely. We also offer consultancy services in the run-up to a GMP inspection, representation of international pharmaceutical companies and distribution of their products in Germany.